1. Home
  2. STRS vs MIST Comparison

STRS vs MIST Comparison

Compare STRS & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

N/A

Current Price

$23.56

Market Cap

168.1M

Sector

Real Estate

ML Signal

N/A

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$2.34

Market Cap

163.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
MIST
Founded
1992
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
168.1M
163.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STRS
MIST
Price
$23.56
$2.34
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
9.3K
5.3M
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,912,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.10
$0.63
52 Week High
$26.05
$3.06

Technical Indicators

Market Signals
Indicator
STRS
MIST
Relative Strength Index (RSI) 66.60 46.37
Support Level $20.75 $1.61
Resistance Level $24.00 $3.06
Average True Range (ATR) 0.96 0.31
MACD 0.23 -0.04
Stochastic Oscillator 91.77 48.62

Price Performance

Historical Comparison
STRS
MIST

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: